Direct medical cost of asthma in Ankara, Turkey.
Respiration
; 71(6): 587-93, 2004.
Article
em En
| MEDLINE
| ID: mdl-15627869
ABSTRACT
BACKGROUND:
There has been no documented data regarding the cost of asthma in our country.OBJECTIVE:
In this 1-year prospective study, we aimed to determine the annual cost of asthma in Ankara, Turkey.METHODS:
Direct medical cost analysis was performed in 118 patients.RESULTS:
Mean annual direct medical costs of asthma were USD 1,465.7 +/- 111.8 per capita. Medication cost comprised the majority (81%) of the total direct cost. Mean direct medical costs according to the stage of disease were USD 172.5 +/- 51.7, 860.7 +/- 70.2, 1,671.6 +/- 141.8 and 3,491.9 +/- 417.6 for stage 1 (n = 4), 2 (n = 54), 3 (n = 46) and 4 (n = 14) patients, respectively.CONCLUSIONS:
In this first study to document the cost of asthma for our region, direct cost of asthma was found to be increased with the severity of the illness. Considering the fact that medication cost comprises the major fraction of the direct cost, cost-effectiveness trials to determine the effective treatment with optimal cost for different asthma stages should be the next step.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Asma
/
Custos Diretos de Serviços
Tipo de estudo:
Health_economic_evaluation
/
Observational_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
País como assunto:
Asia
Idioma:
En
Ano de publicação:
2004
Tipo de documento:
Article